BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Bo Qin, Yechao Zhou, Guozhong Zhou, Xiuping Xu, Yanan Wang, Jinkun Chen. Substitutions of rtL228 and/or L229 are involved in the regulation of replication and HBsAg secretion in hepatitis B virus, and do not affect susceptibility to nucleos(t)ide analogsMolecular Medicine Reports 2017; 16(6): 9678 doi: 10.3892/mmr.2017.7778
2
Forough Golsaz-Shirazi, Fazel Shokri. Hepatitis B immunopathogenesis and immunotherapyImmunotherapy 2016; 8(4): 461 doi: 10.2217/imt.16.3
3
Jun Chen, Shu-Shan Zhao, Xiao-xiao Liu, Ze-Bing Huang, Yan Huang. Comparison of the Efficacy of Tenofovir Versus Tenofovir plus Entecavir in the Treatment of Chronic Hepatitis B in Patients With Poor Efficacy of Entecavir: A Systematic Review and Meta-analysisClinical Therapeutics 2017; 39(9): 1870 doi: 10.1016/j.clinthera.2017.07.015
4
Lujie Liu, Yan Liu, Rongjuan Chen, Xiaodong Li, Dan Luo, Yangyang Zhao, Qi Li, Bixia Huang, Fu-Sheng Wang, Xinguang Liu, Dongping Xu. Prevalence of the entecavir-resistance-inducing mutation rtA186T in a large cohort of Chinese hepatitis B virus patientsAntiviral Research 2019; 164: 131 doi: 10.1016/j.antiviral.2019.02.012